WEDNESDAY, Aug. 16, 2023 (HealthDay News) — All infants should receive the new long-acting preventive monoclonal antibody for respiratory syncytial virus (RSV), the nation’s leading pediatrics group said. The American Academy of Pediatrics (AAP) urged that access to the new medication, called nirsevimab, be equitable. RSV is common, contagious andContinue Reading

FRIDAY, Aug. 4, 2023 (HealthDay News) — The trauma and unhappy family dynamics of childhood may follow kids into old age, affecting both their mind and body, according to new research. “We looked at self-reported disability, as well as objectively measured physical and cognitive impairment, and learned that early-life stressfulContinue Reading